Condensed Consolidated Statements of Cash Flows - USD ($)	1 Months Ended	3 Months Ended		9 Months Ended		12 Months Ended
	Jan. 30, 2015	Oct. 02, 2015	Oct. 31, 2014	Oct. 02, 2015	Oct. 31, 2014	Jan. 30, 2015
Cash flows from operations:
Net income (loss)		$ 49,000,000	$ 34,000,000	$ 127,000,000	$ (367,000,000)
(Income) loss from discontinued operations		0	4,000,000	(18,000,000)	11,000,000
Adjustments to reconcile net income (loss) to net cash provided by operations:
Depreciation and amortization				35,000,000	50,000,000
Stock-based compensation				23,000,000	33,000,000
Goodwill impairment charges			0	0	486,000,000	$ 486,000,000
Asset impairment charges		4,000,000	17,000,000	73,000,000	41,000,000
Bad debt expense and other				8,000,000	7,000,000
Change in assets and liabilities, net of effects of acquisitions and dispositions:
Receivables				145,000,000	29,000,000
Inventory, prepaid expenses and other current assets				(22,000,000)	(4,000,000)
Deferred income taxes				8,000,000	46,000,000
Accounts payable and accrued liabilities				71,000,000	(11,000,000)
Accrued payroll and employee benefits				(26,000,000)	3,000,000
Income taxes receivable/payable				(28,000,000)	(16,000,000)
Other long-term assets/liabilities				(18,000,000)	(14,000,000)
Total cash flows provided by operating activities of continuing operations	$ 11,000,000			378,000,000	294,000,000
Cash flows from investing activities:
Expenditures for property, plant and equipment				(15,000,000)	(26,000,000)
Payments on accrued purchase price related to prior acquisition				(13,000,000)	0
Proceeds from sale of assets				9,000,000	0
Proceeds from disposition of business, net of cash sold of $2 million				27,000,000	0
Proceeds from U.S. Treasury cash grant				0	80,000,000
Total cash flows provided by investing activities of continuing operations				8,000,000	54,000,000
Cash flows from financing activities:
Payments of notes payable and long-term debt				(49,000,000)	(104,000,000)
Sales of stock and exercises of stock options				4,000,000	6,000,000
Repurchases of stock and stock received for tax withholdings				(116,000,000)	(213,000,000)
Dividend payments				(71,000,000)	(72,000,000)
Other				3,000,000	1,000,000
Total cash flows used in financing activities of continuing operations	(47,000,000)			(229,000,000)	(382,000,000)
Increase (decrease) in cash and cash equivalents from continuing operations				157,000,000	(34,000,000)
Cash flows from discontinued operations:
Cash provided by (used in) operating activities of discontinued operations				13,000,000	(5,000,000)
Cash provided by investing activities of discontinued operations				6,000,000	27,000,000
Increase in cash and cash equivalents from discontinued operations	20,000,000			19,000,000	22,000,000
Increase in cash and cash equivalents from discontinued operations	(16,000,000)			176,000,000	(12,000,000)
Cash and cash equivalents at beginning of period	459,000,000			459,000,000	430,000,000	430,000,000
Cash and cash equivalents at end of period		635,000,000	418,000,000	635,000,000	418,000,000
Leidos, Inc.
Cash flows from operations:
Net income (loss)		51,000,000	36,000,000	133,000,000	(362,000,000)
(Income) loss from discontinued operations		0	4,000,000	(18,000,000)	11,000,000
Adjustments to reconcile net income (loss) to net cash provided by operations:
Depreciation and amortization				35,000,000	50,000,000
Stock-based compensation				23,000,000	33,000,000
Goodwill impairment charges		0	0	0	486,000,000
Asset impairment charges		4,000,000	17,000,000	73,000,000	41,000,000
Bad debt expense and other				2,000,000	2,000,000
Change in assets and liabilities, net of effects of acquisitions and dispositions:
Receivables				145,000,000	29,000,000
Inventory, prepaid expenses and other current assets				(22,000,000)	(4,000,000)
Deferred income taxes				8,000,000	46,000,000
Accounts payable and accrued liabilities				71,000,000	(11,000,000)
Accrued payroll and employee benefits				(26,000,000)	3,000,000
Income taxes receivable/payable				(28,000,000)	(16,000,000)
Other long-term assets/liabilities				(18,000,000)	(14,000,000)
Total cash flows provided by operating activities of continuing operations				378,000,000	294,000,000
Cash flows from investing activities:
Proceeds on obligations of Leidos Holdings, Inc.				20,000,000	82,000,000
Payments on obligations of Leidos Holdings, Inc.				(200,000,000)	(360,000,000)
Expenditures for property, plant and equipment				(15,000,000)	(26,000,000)
Payments on accrued purchase price related to prior acquisition				(13,000,000)	0
Proceeds from sale of assets				9,000,000	0
Proceeds from disposition of business, net of cash sold of $2 million				27,000,000	0
Proceeds from U.S. Treasury cash grant				0	80,000,000
Total cash flows provided by investing activities of continuing operations				(172,000,000)	(224,000,000)
Cash flows from financing activities:
Payments of notes payable and long-term debt				(49,000,000)	(104,000,000)
Total cash flows used in financing activities of continuing operations				(49,000,000)	(104,000,000)
Increase (decrease) in cash and cash equivalents from continuing operations				157,000,000	(34,000,000)
Cash flows from discontinued operations:
Cash provided by (used in) operating activities of discontinued operations				13,000,000	(5,000,000)
Cash provided by investing activities of discontinued operations				6,000,000	27,000,000
Increase in cash and cash equivalents from discontinued operations				19,000,000	22,000,000
Increase in cash and cash equivalents from discontinued operations				176,000,000	(12,000,000)
Cash and cash equivalents at beginning of period	$ 459,000,000			459,000,000	430,000,000	$ 430,000,000
Cash and cash equivalents at end of period		$ 635,000,000	$ 418,000,000	$ 635,000,000	$ 418,000,000